Evidence map›Paper›PMID 16293194›Full record

ReviewRetrovirology2005

Review of the twelfth West Coast Retrovirus Meeting.

Sheila M Barry, Marta Melar, Philippe Gallay, Thomas J Hope

Abstract readReview
In one paragraph

Review in Retrovirology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sheila M BarryDepartment of Cell and Molecular Biology, College of Medicine, Northwestern University, Chicago, IL 60611, USA. s-barry@northwestern.edu
Marta Melar
Philippe Gallay
Thomas J Hope

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Every year the Cancer Research Institute from University of California at Irvine organizes the West Coast Retrovirus Meeting where participants have a chance to discuss the latest progress in understanding the pathology of retroviruses. The 12th meeting was held at the Hyatt Regency Suites in Palm Springs, California from October 6th to October 9th 2005, with the major focus on human immunodeficiency virus (HIV) pathogenesis. Philippe Gallay from The Scripps Research Institute and Thomas J. Hope from Northwestern University organized the meeting, which covered all the steps involved in the lifecycle of retroviruses with an emphasis on virus:host interactions. The trend in research appeared to be on the restriction of viral infection, both by the endogenous, cellular restriction factors, as well as by the potential antimicrobial compounds of known or unknown mechanisms. Additionally, new stories on the inevitable feedback from the host immune system were presented as well. HIV still represents a challenge that an army of motivated people has been working on for over 20 years. And yet, the field has not reached the plateau in knowledge nor enthusiasm, which was proven again in October 2005 in Palm Springs.

Indexed as

Anti-HIV AgentsCalciumCD4-Positive T-LymphocytesGene Products, nefGene Products, vifGene Products, vprHIV-1HIV Envelope Protein gp41HIV InfectionsHuman Immunodeficiency Virus ProteinsHumansnef Gene Products, Human Immunodeficiency VirusNF-kappa BPositive Transcriptional Elongation Factor Bvif Gene Products, Human Immunodeficiency VirusViral Regulatory and Accessory ProteinsAnti-HIV AgentsCalciumGene Products, nefGene Products, vifGene Products, vprHIV Envelope Protein gp41Human Immunodeficiency Virus Proteinsnef Gene Products, Human Immunodeficiency VirusNF-kappa BPositive Transcriptional Elongation Factor Bvif Gene Products, Human Immunodeficiency VirusViral Regulatory and Accessory ProteinsViroporin Proteinsvpr Gene Products, Human Immunodeficiency Virusvpu protein, Human immunodeficiency virus 1

Identifiers

PMID16293194
PMCPMC1315336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.